| Mucin dynamics and enteric pathogens MA McGuckin, SK Lindén, P Sutton, TH Florin Nature Reviews Microbiology 9 (4), 265-278, 2011 | 1512 | 2011 |
| Mucins in the mucosal barrier to infection SK Linden, P Sutton, NG Karlsson, V Korolik, MA McGuckin Mucosal immunology 1 (3), 183-197, 2008 | 1302 | 2008 |
| MUC1 Limits Helicobacter pylori Infection both by Steric Hindrance and by Acting as a Releasable Decoy SK Lindén, YH Sheng, AL Every, KM Miles, EC Skoog, THJ Florin, ... PLoS pathogens 5 (10), e1000617, 2009 | 310 | 2009 |
| In vivo immunosuppressive activity of gliotoxin, a metabolite produced by human pathogenic fungi P Sutton, NR Newcombe, P Waring, A Müllbacher Infection and Immunity 62 (4), 1192-1198, 1994 | 211 | 1994 |
| Muc1 mucin limits both Helicobacter pylori colonization of the murine gastric mucosa and associated gastritis MA McGuckin, AL Every, CD Skene, SK Linden, YT Chionh, A Swierczak, ... Gastroenterology 133 (4), 1210-1218, 2007 | 210 | 2007 |
| Biomedical applications of sheep models: from asthma to vaccines JPY Scheerlinck, KJ Snibson, VM Bowles, P Sutton Trends in biotechnology 26 (5), 259-266, 2008 | 183 | 2008 |
| Saponin-adjuvanted particulate vaccines for clinical use CD Skene, P Sutton Methods 40 (1), 53-59, 2006 | 182 | 2006 |
| MUC1 and MUC13 differentially regulate epithelial inflammation in response to inflammatory and infectious stimuli YH Sheng, S Triyana, R Wang, I Das, K Gerloff, TH Florin, P Sutton, ... Mucosal immunology 6 (3), 557-568, 2013 | 139 | 2013 |
| Therapeutic immunization against Helicobacter pylori infection in the absence of antibodies P Sutton, J Wilson, T Kosaka, I Wolowczuk, A Lee Immunology and cell biology 78 (1), 28-30, 2000 | 138 | 2000 |
| Intranasal vaccination with ISCOMATRIX® adjuvanted influenza vaccine A Coulter, R Harris, R Davis, D Drane, J Cox, D Ryan, P Sutton, ... Vaccine 21 (9-10), 946-949, 2003 | 135 | 2003 |
| Systems serology detects functionally distinct coronavirus antibody features in children and elderly KJ Selva, CE Van De Sandt, MM Lemke, CY Lee, SK Shoffner, BY Chua, ... Nature communications 12 (1), 2037, 2021 | 133 | 2021 |
| The MUC13 cell-surface mucin protects against intestinal inflammation by inhibiting epithelial cell apoptosis YH Sheng, R Lourie, SK Lindén, PL Jeffery, D Roche, TV Tran, CW Png, ... Gut 60 (12), 1661-1670, 2011 | 128 | 2011 |
| Status of vaccine research and development for Helicobacter pylori P Sutton, JM Boag Vaccine 37 (50), 7295-7299, 2019 | 127 | 2019 |
| Immune responses to SARS-CoV-2 in three children of parents with symptomatic COVID-19 S Tosif, MR Neeland, P Sutton, PV Licciardi, S Sarkar, KJ Selva, LAH Do, ... Nature communications 11 (1), 5703, 2020 | 113 | 2020 |
| Post-immunisation gastritis and Helicobacterinfection in the mouse: a long term study P Sutton, SJ Danon, M Walker, LJ Thompson, J Wilson, T Kosaka, A Lee Gut 49 (4), 467-473, 2001 | 108 | 2001 |
| Exacerbation of invasive aspergillosis by the immunosuppressive fungal metabolite, gliotoxin P Sutton, P Waring, A Müllbacher Immunology and cell biology 74 (4), 318-322, 1996 | 107 | 1996 |
| The endotoxin of Helicobacter pylori is a modulator of host-dependent gastritis T Sakagami, J Vella, MF Dixon, J O'Rourke, F Radcliff, P Sutton, ... Infection and immunity 65 (8), 3310-3316, 1997 | 105 | 1997 |
| The MUC1 mucin protects against Helicobacter pylori pathogenesis in mice by regulation of the NLRP3 inflammasome GZ Ng, TR Menheniott, AL Every, A Stent, LM Judd, YT Chionh, P Dhar, ... Gut 65 (7), 1087-1099, 2016 | 104 | 2016 |
| Bioactivity in an aggrecan 32‐mer fragment is mediated via Toll‐like receptor 2 S Lees, SB Golub, K Last, W Zeng, DC Jackson, P Sutton, AJ Fosang Arthritis & rheumatology 67 (5), 1240-1249, 2015 | 95 | 2015 |
| Innate cell profiles during the acute and convalescent phase of SARS-CoV-2 infection in children MR Neeland, S Bannister, V Clifford, K Dohle, K Mulholland, P Sutton, ... Nature communications 12 (1), 1084, 2021 | 92 | 2021 |
Garrett NgHudson Institute of Medical ResearchVerified email at hudson.org.au
